Tyrosine kinase 2

Tyrosine kinase 2

Tyrosine kinase 2, also known as TYK2, is a human gene.cite web | title = Entrez Gene: TYK2 tyrosine kinase 2| url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=7297| accessdate = ]

Tyk2 was the first member of the JAK family that was described. It has been implicated in IFN-α, IL-6, IL-10 and IL-12 signaling.

External links

*

References

Further reading

PBB_Further_reading
citations =
*cite journal | author=Velazquez L, Fellous M, Stark GR, Pellegrini S |title=A protein tyrosine kinase in the interferon alpha/beta signaling pathway. |journal=Cell |volume=70 |issue= 2 |pages= 313–22 |year= 1992 |pmid= 1386289 |doi=
*cite journal | author=Krolewski JJ, Lee R, Eddy R, "et al." |title=Identification and chromosomal mapping of new human tyrosine kinase genes. |journal=Oncogene |volume=5 |issue= 3 |pages= 277–82 |year= 1990 |pmid= 2156206 |doi=
*cite journal | author=Firmbach-Kraft I, Byers M, Shows T, "et al." |title=tyk2, prototype of a novel class of non-receptor tyrosine kinase genes. |journal=Oncogene |volume=5 |issue= 9 |pages= 1329–36 |year= 1990 |pmid= 2216457 |doi=
*cite journal | author=Partanen J, Mäkelä TP, Alitalo R, "et al." |title=Putative tyrosine kinases expressed in K-562 human leukemia cells. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=87 |issue= 22 |pages= 8913–7 |year= 1991 |pmid= 2247464 |doi=
*cite journal | author=Colamonici O, Yan H, Domanski P, "et al." |title=Direct binding to and tyrosine phosphorylation of the alpha subunit of the type I interferon receptor by p135tyk2 tyrosine kinase. |journal=Mol. Cell. Biol. |volume=14 |issue= 12 |pages= 8133–42 |year= 1994 |pmid= 7526154 |doi=
*cite journal | author=Novak U, Harpur AG, Paradiso L, "et al." |title=Colony-stimulating factor 1-induced STAT1 and STAT3 activation is accompanied by phosphorylation of Tyk2 in macrophages and Tyk2 and JAK1 in fibroblasts. |journal=Blood |volume=86 |issue= 8 |pages= 2948–56 |year= 1995 |pmid= 7579387 |doi=
*cite journal | author=Domanski P, Yan H, Witte MM, "et al." |title=Homodimerization and intermolecular tyrosine phosphorylation of the Tyk-2 tyrosine kinase. |journal=FEBS Lett. |volume=374 |issue= 3 |pages= 317–22 |year= 1995 |pmid= 7589562 |doi=
*cite journal | author=Yetter A, Uddin S, Krolewski JJ, "et al." |title=Association of the interferon-dependent tyrosine kinase Tyk-2 with the hematopoietic cell phosphatase. |journal=J. Biol. Chem. |volume=270 |issue= 31 |pages= 18179–82 |year= 1995 |pmid= 7629131 |doi=
*cite journal | author=Maruyama K, Sugano S |title=Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides. |journal=Gene |volume=138 |issue= 1-2 |pages= 171–4 |year= 1994 |pmid= 8125298 |doi=
*cite journal | author=Trask B, Fertitta A, Christensen M, "et al." |title=Fluorescence in situ hybridization mapping of human chromosome 19: cytogenetic band location of 540 cosmids and 70 genes or DNA markers. |journal=Genomics |volume=15 |issue= 1 |pages= 133–45 |year= 1993 |pmid= 8432525 |doi=
*cite journal | author=Platanias LC, Uddin S, Yetter A, "et al." |title=The type I interferon receptor mediates tyrosine phosphorylation of insulin receptor substrate 2. |journal=J. Biol. Chem. |volume=271 |issue= 1 |pages= 278–82 |year= 1996 |pmid= 8550573 |doi=
*cite journal | author=Gauzzi MC, Velazquez L, McKendry R, "et al." |title=Interferon-alpha-dependent activation of Tyk2 requires phosphorylation of positive regulatory tyrosines by another kinase. |journal=J. Biol. Chem. |volume=271 |issue= 34 |pages= 20494–500 |year= 1996 |pmid= 8702790 |doi=
*cite journal | author=Uddin S, Gardziola C, Dangat A, "et al." |title=Interaction of the c-cbl proto-oncogene product with the Tyk-2 protein tyrosine kinase. |journal=Biochem. Biophys. Res. Commun. |volume=225 |issue= 3 |pages= 833–8 |year= 1996 |pmid= 8780698 |doi= 10.1006/bbrc.1996.1259
*cite journal | author=Zou J, Presky DH, Wu CY, Gubler U |title=Differential associations between the cytoplasmic regions of the interleukin-12 receptor subunits beta1 and beta2 and JAK kinases. |journal=J. Biol. Chem. |volume=272 |issue= 9 |pages= 6073–7 |year= 1997 |pmid= 9038232 |doi=
*cite journal | author=Miyakawa Y, Oda A, Druker BJ, "et al." |title=Thrombopoietin and thrombin induce tyrosine phosphorylation of Vav in human blood platelets. |journal=Blood |volume=89 |issue= 8 |pages= 2789–98 |year= 1997 |pmid= 9108397 |doi=
*cite journal | author=Uddin S, Sher DA, Alsayed Y, "et al." |title=Interaction of p59fyn with interferon-activated Jak kinases. |journal=Biochem. Biophys. Res. Commun. |volume=235 |issue= 1 |pages= 83–8 |year= 1997 |pmid= 9196040 |doi= 10.1006/bbrc.1997.6741
*cite journal | author=Burfoot MS, Rogers NC, Watling D, "et al." |title=Janus kinase-dependent activation of insulin receptor substrate 1 in response to interleukin-4, oncostatin M, and the interferons. |journal=J. Biol. Chem. |volume=272 |issue= 39 |pages= 24183–90 |year= 1997 |pmid= 9305869 |doi=
*cite journal | author=Gauzzi MC, Barbieri G, Richter MF, "et al." |title=The amino-terminal region of Tyk2 sustains the level of interferon alpha receptor 1, a component of the interferon alpha/beta receptor. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=94 |issue= 22 |pages= 11839–44 |year= 1997 |pmid= 9342324 |doi=
*cite journal | author=Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, "et al." |title=Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library. |journal=Gene |volume=200 |issue= 1-2 |pages= 149–56 |year= 1997 |pmid= 9373149 |doi=
*cite journal | author=Ahmad S, Alsayed YM, Druker BJ, Platanias LC |title=The type I interferon receptor mediates tyrosine phosphorylation of the CrkL adaptor protein. |journal=J. Biol. Chem. |volume=272 |issue= 48 |pages= 29991–4 |year= 1997 |pmid= 9374471 |doi=

PBB_Controls
update_page = yes
require_manual_inspection = no
update_protein_box = yes
update_summary = yes
update_citations = yes


Wikimedia Foundation. 2010.

Игры ⚽ Нужно сделать НИР?

Look at other dictionaries:

  • Tyrosine kinase — A tyrosine kinase is an enzyme that can transfer a phosphate group from ATP to a tyrosine residue in a protein. Tyrosine kinases are a subgroup of the larger class of protein kinases. Phosphorylation of proteins by kinases is an important… …   Wikipedia

  • Tyrosine kinase — Récepteur Tyrosine Kinase Pour les articles homonymes, voir RTK. Les Récepteurs à activité Tyrosine Kinase (RTK) font partie de la famille des récepteurs enzymes. Ce sont tous des récepteurs transmembranaires monomérique exception faite pour l… …   Wikipédia en Français

  • tyrosine kinase — Kinases that phosphorylate protein tyrosine residues. These kinases play major roles in mitogenic signalling, and can be divided into two subfamilies: receptor tyrosine kinases, that have an extracellular ligand binding domain, a single… …   Dictionary of molecular biology

  • tyrosine kinase — ty·ro·sine ki·nase (tiґro sēn kiґnās) protein tyrosine kinase …   Medical dictionary

  • tyrosine kinase inhibitor BIBF 1120 — A substance being studied in the treatment of some types of cancer. Tyrosine kinase inhibitor BIBF 1120 blocks enzymes needed for cells to grow, and may prevent the growth of new blood vessels needed for tumors to grow. It is a type of tyrosine… …   English dictionary of cancer terms

  • tyrosine kinase inhibitor — any of a class of antineoplastic agents that inhibit protein tyrosine kinase and interfere with the action of epidermal growth factor in cancer cells …   Medical dictionary

  • tyrosine kinase inhibitor — A drug that interferes with cell communication and growth and may prevent tumor growth. Some tyrosine kinase inhibitors are used to treat cancer …   English dictionary of cancer terms

  • tyrosine kinase phosphorylation site — Substrates of tyrosine protein kinases are generally characterized by a lysine or an arginine seven residues to the N terminal side of the phosphorylated tyrosine, and an acidic residue (Asp or Glu) three or four residues to the N terminal side… …   Dictionary of molecular biology

  • tyrosine kinase inhibitor — any one of a class of drugs that interfere with cell growth in a variety of different ways by inhibiting the action of tyrosine kinases. This family of enzymes, which occur both within cells and as components of cell membrane receptor sites, have …   The new mediacal dictionary

  • Bcr-Abl tyrosine-kinase inhibitor — Bcr Abl tyrosine kinase inhibitors (TKI) are the first line therapy for most patients with chronic myelogenous leukemia (CML). In more than 90% cases CML is caused by chromosomal abnormality resulting in the formation of a so called Philadelphia… …   Wikipedia

Share the article and excerpts

Direct link
… Do a right-click on the link above
and select “Copy Link”